The rapid expansion of social media platforms has significantly influenced communication, education, and professional interaction within the field of metabolic and bariatric surgery. Surgeons increasingly engage with platforms such as Facebook, Instagram, X (formerly Twitter), and TikTok for patient education, professional networking, academic exchange, and the dissemination of surgical and scientific information.
Social media has also become an important source of information and support for patients before and after metabolic and bariatric surgery, facilitating access to peer communities and health-related content. However, the accuracy, quality, and ethical standards of information shared on these platforms remain inconsistent. A considerable volume of content is produced by non-medical individuals, raising concerns regarding misinformation, patient safety, professional conduct, and the potential influence on patient expectations and decision-making.
In this context, a comprehensive understanding of current social media practices among metabolic and bariatric surgeons worldwide is essential. This IFSO-endorsed survey aims to assess patterns of social media use, motivations, perceived benefits, challenges, and ethical considerations from the perspective of practicing surgeons. The results will contribute to the development of evidence-based recommendations, support responsible digital engagement, and inform future educational initiatives and policy guidance within the global metabolic and bariatric surgery community.
Participation Information
Voluntary participation: Participation is entirely voluntary, and you may choose to discontinue at any point without consequence.
Consent: Participation in the survey constitutes consent to use your responses for academic and professional research purposes.
Time commitment: The survey takes approximately 15 minutes to complete.
Data management: No third-party data collection provider is involved, and survey data will not be shared with any external entity.
Funding: The survey distribution fee (USD $500) is covered personally by the principal investigator. No external funding or sponsorship has been received.
Collaboration and endorsement: This survey is conducted in collaboration with an international research team and is endorsed by the International Federation for the Surgery and Other Therapies for Obesity (IFSO). Collaborative authorship will be offered to respondents who wish to provide their professional information, in accordance with established academic authorship criteria.
With sincere appreciation,
Thibaut Coste MD (France)
Panagiotis Lainas MD, MSc, MSurg, PhD (Greece)
Tamer Abdelbaki MD, PhD (Egypt)
Carlos Zerrweck MD, PhD (Mexico)
Sonja Chiappetta MD, PhD (Italy)
Daniel Moritz Felsenreich MD, PhD (Austria)